Endoscopic-assisted Microsurgical Removal of Cerebellopontine Angle Lesions

Cerebellopontine Angle Tumor Clinical Trial

Official title:

Evaluation of Endoscopic-assisted Microsurgical Removal of Cerebellopontine Angle Lesions

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03228511
• Other study ID #: Easpost fossa
• Status: Not yet recruiting
• Phase: N/A
• First received: July 18, 2017
• Last updated: July 21, 2017
• Start date: August 1, 2017
• Est. completion date: March 2021

Study information

• Verified date: July 2017
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It is a Prospective descriptive hospital based clinical study to determine the value of introduction of endoscope after microscopic excision of cerebello-pontine angle lesions to estimate the following :

1. Intraoperative judgement of lesions excision, residual parts, visualization and operative corridor pre and after endoscope introduction.

2. Post-operative tumor control confirmed comparison between pre and postoperative MRI.

3. Postoperative complications, advantages and disadvantages compared with these when use pure microscopic excision from the literature

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1
• Est. completion date: March 2021
• Est. primary completion date: January 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria: cerebellopontine angle lesions

• meningeoma.

• vestibular schwannoma.

• arachnoid cyst.

• petroclival meningeoma.

Exclusion Criteria:

• trigeminal neuralgia.

• facial neuralgia.

Related Conditions & MeSH terms

• Cerebellopontine Angle Tumor
• Neuroma, Acoustic

Intervention

Device:
• endoscope
It is a Prospective descriptive hospital based clinical study to determine the value of introduction of endoscope after microscopic excision of cerebello-pontine angle lesions

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	post operative residual tumor	post operative MRI will be done and will be compared with the preoperative one to determine if complete excision was done or if there is residual parts	1 week